Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin
Articolo
Data di Pubblicazione:
2006
Tipologia CRIS:
03A-Articolo su Rivista
Keywords:
Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Fibronectins; Immunity, Cellular; Immunoglobulin Fragments; Immunotherapy, Adoptive; Melphalan; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasms, Experimental; Recombinant Fusion Proteins; Spleen; Survival Analysis; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Time Factors; Tumor Necrosis Factor-alpha; Oncology; Cancer Research
Elenco autori:
Balza, Enrica; Mortara, Lorenzo; Sassi, Francesca; Monteghirfo, Stefano; Carnemolla, Barbara; Castellani, Patrizia; Neri, Dario; Accolla, Roberto S.; Zardi, Luciano; Borsi, Laura
Link alla scheda completa:
Link al Full Text:
Pubblicato in: